CJC-1295 research guide

CJC-1295 in Igea — GHRH Analog Research Guide

CJC-1295 research guide for Igea. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.

Skip to Sourcing Guide Order CJC-1295 →

Finding CJC-1295 in Igea

The search for CJC-1295 in Igea reliably produces the same conclusion: research peptides are sourced from specialist online vendors, not local retail. This concentration of supply in online vendors is a genuine benefit for researchers — top vendors distinguish themselves through rigorous testing in ways brick-and-mortar outlets simply cannot. Vendors worth sourcing from proactively publish batch-matched Certificates of Analysis showing HPLC purity data, mass spec identity confirmation, endotoxin levels, and residual solvent results — all for the specific lot you are purchasing. This guide guides Igea researchers through that evaluation process and explains how to verify CJC-1295 vendor quality step by step.

What Studies Say About CJC-1295

The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Igea researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.

How to Evaluate CJC-1295 Vendors

Evaluating CJC-1295 vendors requires starting from the COA: access the batch-specific certificate before placing an order, not after. The HPLC chromatogram is the most important document in the COA: it should show a large primary peak representing CJC-1295, with small or absent impurity peaks representing impurities — purity should be at or above 98%. Strong quality indicators beyond COA quality: multi-year operating history, responsive technical support who understand testing methodology, and temperature-appropriate packaging with desiccant. For Igea researchers making a first CJC-1295 purchase: work through this evaluation framework first, order conservatively at first, and verify batch traceability on arrival before use.

Order CJC-1295 — ships to Igea
COA-verified · International tracking · Research grade
Order Now →

CJC-1295 Safety, Handling & Research Protocols

Research compound status for CJC-1295 means risk characterisation relies on animal studies, in-vitro work, and limited human observations — rather than the controlled trials that generate pharmaceutical safety profiles. Proper handling of CJC-1295 requires strict sterile technique during reconstitution — prep pad-cleaned septum, single-use needles, uncontaminated workspace — and temperature control throughout the entire workflow. The main safety concern arising from sourcing in CJC-1295 research is endotoxin from inadequately tested product — a confirmed endotoxin test result in the lot-matched COA is the key safeguard. For any individual considering CJC-1295 outside a formal research context: speak with a healthcare professional — this compound is not a licensed human medication and its safety characterisation does not match that of regulated drugs.

Frequently Asked Questions

What is CJC-1295?

CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.

What purity is required for CJC-1295 research?

CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.

Order CJC-1295 today
COA-verified · International shipping available
Order Now →